Clinical Trials Browser

Phase 1 × Carcinoma, Hepatocellular × Receptor Protein-Tyrosine Kinases × Clear all

NCT00956436 2013-09-16

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Phase 1 Completed

Gastrointestinal

Insulin-Like Growth Factor I, Resistance To, Carcinoma, Hepatocellular, Liver Neoplasms

NCT01266707 2010-12-24

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Phase 1 Unknown

Gastrointestinal

Carcinoma, Hepatocellular